Atractylodin alleviates neuroinflammation and protects neurological function after ischemic stroke in association with reduced NLRP3 inflammasome activation

Read full text Summarise with VIRAT
Authors: Qingyao Ouyang, Yiying Yang, Hoi Leong Lee, Ziyu Yan, Dezhi Deng, Wei Li
Cited by: 0
References: 32

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Background: NOD-like receptor protein 3 (NLRP3) inflammasome-driven neuroinflammation contributes to ischemic stroke injury. Atractylodin (ART) shows anti-inflammatory activity, but its neuroprotective potential and mechanistic links to NLRP3 signaling after cerebral ischemia-reperfusion (I/R) injury remain to be defined. Materials and methods: . Neurobehavioral outcomes and infarct volume were assessed in MCAO rats, along with measurements of neuronal apoptosis. NLRP3 inflammasome activation, gasdermin D (GSDMD)-dependent pyroptosis, pro-inflammatory cytokines, and microglial polarization markers were evaluated using immunoblotting, immunofluorescence, RT-qPCR, and enzyme-linked immunosorbent assay (ELISA). Results: In OGD/R-stimulated BV2 microglia, ART suppressed NLRP3 inflammasome activation and reduced GSDMD cleavage, accompanied by decreased IL-1β and IL-18 production. In the MCAO model, ART significantly improved neurological outcomes and reduced infarct volume and neuronal apoptosis. These protective effects were linked to a reduction in the expression of NLRP3 pathway components (NLRP3, ASC, and caspase-1) and GSDMD-N. Additionally, there was a shift in microglial responses toward an anti-inflammatory (M2-like) profile, which led to a decrease in pro-inflammatory markers. Conclusion: ART confers neuroprotection in experimental ischemic stroke by inhibiting NLRP3 inflammasome-associated pyroptosis and modulating microglial inflammatory polarization, supporting its potential as a therapeutic candidate for ischemic stroke.

Fields of Study & Subjects

Neuroinflammation and Neurodegeneration Mechanisms Inflammasome and immune disorders Neurological Disease Mechanisms and Treatments

Publication details

Journal / source
Frontiers in Neurology
Volume
17
Pages
1754614–1754614
Publication date
27 March 2026
Language
EN